Psychiatric neuromodulation: the underappreciated importance of pre- and post-treatment care

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1
Fig. 2

References

  1. 1.

    Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163:1905–17.

    Article  Google Scholar 

  2. 2.

    Weiskopf. Models and mechanisms in psychological explanation. Synthese. 2011;183:313–38.

    Article  Google Scholar 

  3. 3.

    Paulus MP. Pragmatism instead of mechanism: a call for impactful biological psychiatry. JAMA Psychiatry. 2015;72:631–2.

    Article  Google Scholar 

  4. 4.

    Ruck C, Larsson KJ, Mataix-Cols D. Predictors of medium and long-term outcome following capsulotomy for obsessive-compulsive disorder: one site may not fit all. Eur Neuropsychopharmacol. 2012;22:406–14.

    CAS  Article  Google Scholar 

  5. 5.

    Gentil AF, Lopes AC, Dougherty DD, Ruck C, Mataix-Cols D, Lukacs TL, et al. Hoarding symptoms and prediction of poor response to limbic system surgery for treatment-refractory obsessive-compulsive disorder. J Neurosurg. 2014;121:123–30.

    Article  Google Scholar 

  6. 6.

    Denys D, Mantione M, Figee M, van den Munckhof P, Koerselman F, Westenberg H, et al. Deep brain stimulation of the nucleus accumbens for treatment-refractory obsessive-compulsive disorder. Arch Gen Psychiatry. 2010;67:1061–8.

    Article  Google Scholar 

  7. 7.

    Mantione M, Nieman DH, Figee M, Denys D. Cognitive-behavioural therapy augments the effects of deep brain stimulation in obsessive-compulsive disorder. Psychol Med. 2014;44:3515–22.

    CAS  Article  Google Scholar 

  8. 8.

    Atiku L, Gorst-Unsworth C, Khan BU, Huq F, Gordon J. Improving relapse prevention after successful electroconvulsive therapy for patients with severe depression: completed audit cycle involving 102 full electroconvulsive therapy courses in West Sussex, United kingdom. J Ect. 2015;31:34–6.

    Article  Google Scholar 

  9. 9.

    van den Broek WW, Birkenhager TK, Mulder PG, Bruijn JA, Moleman P. Imipramine is effective in preventing relapse in electroconvulsive therapy-responsive depressed inpatients with prior pharmacotherapy treatment failure: a randomized, placebo-controlled trial. J Clin Psychiatry. 2006;67:263–8.

    Article  Google Scholar 

  10. 10.

    Sackeim HA, Haskett RF, Mulsant BH, Thase ME, Mann JJ, Pettinati HM, et al. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA. 2001;285:1299–307.

    CAS  Article  Google Scholar 

  11. 11.

    Perera T, George MS, Grammer G, Janicak PG, Pascual-Leone A, Wirecki TS. The clinical TMS society consensus review and treatment recommendations for TMS therapy for major depressive disorder. Brain Stimul. 2016;9:336–46.

    Article  Google Scholar 

  12. 12.

    Weiss A, Hussain S, Ng B, Sarma S, Tiller J, Waite S, et al. Royal Australian and New Zealand College of Psychiatrists professional practice guidelines for the administration of electroconvulsive therapy. Aust N Z J Psychiatry. 2019;53:609–23.

    Article  Google Scholar 

  13. 13.

    Sauvaget A, Poulet E, Mantovani A, Bulteau S, Damier P, Moutaud B, et al. The psychiatric neuromodulation unit: implementation and management. J Ect. 2018;34:211–9.

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Contributions

BD made substantial contributions to the conception and design of this work, as well as the acquisition, analysis, and interpretation of the data. He played a major role in drafting the work, and granted final approval of the version to be published. He agrees to be accountable for all aspects of the work. DL made substantial contributions to the acquisition, analysis, and interpretation of the data. He played a major role in drafting the work, and granted final approval of the version to be published. He agrees to be accountable for all aspects of the work. YM made substantial contributions to the acquisition, analysis, and interpretation of the data. She played a major role in drafting the work, and granted final approval of the version to be published. She agrees to be accountable for all aspects of the work. CH made substantial contributions to the acquisition, analysis, and interpretation of the data. He played a major role in drafting the work, and granted final approval of the version to be published. He agrees to be accountable for all aspects of the work. NL made substantial contributions to the conception and design of this work, as well as the acquisition, analysis, and interpretation of the data. He played a major role in drafting the work, and granted final approval of the version to be published. He agrees to be accountable for all aspects of the work.

Corresponding author

Correspondence to Nir Lipsman.

Ethics declarations

Conflict of interest

There are no conflicts of interest to declare. The authors of this study are involved in employing the treatments discussed in this article, but have no financial stake in any of them.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Davidson, B., Li, D.Z., Meng, Y. et al. Psychiatric neuromodulation: the underappreciated importance of pre- and post-treatment care. Mol Psychiatry (2020). https://doi.org/10.1038/s41380-020-0851-0

Download citation